DeGette, Diana

☆

● D · HSE · Colorado — District 1

60%

spoke · 3 of 5 transcribed hearings

21min

speaking time on the record

speaking turns

3,287

words on the record

Talks about biomedical research proposed rule cms sent bill fda

Assignments

Energy and Commerce Committee

House · Standing committee

3 subcommittees

— Energy Subcommittee

— Health Subcommittee · Ranking

— Oversight and Investigations Subcommittee

Speaking record

3 / 5

recent transcribed committee hearings where Rep. DeGette spoke on the record.

On the record

Rep. DeGette's own words —

✓ VALIDATED Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development. Jul 15, 2026

7:16

DeGette, Diana. Thank you so much, Mr. Chairman. I am really excited about this hearing today because I've really worked a lot on biomedical research issues over my career, and I have to I think that I've never seen a more precarious time for the U.S. leadership around the world in biomedical research. The FDA play...

Read the full exchange & watch the clip →

Committee activity

10 recent

HSE

Markup of Sixteen Bills

Energy and Commerce Committee

Sep 16, 2026·10:00 AM

Request a transcript

HSE

Nuclear Spent Fuel Policy: Examining Nuclear Lifecycle Innovation Campuses

Energy Subcommittee

Sep 15, 2026·10:15 AM

Request a transcript

HSE

“Examining Legislative Proposals to Reform Medicare Provider Payment and Bolster Health Care Cybersecurity.”

Health Subcommittee

Sep 15, 2026·10:30 AM

Request a transcript

HSE

Ten Pieces of Legislation

Energy and Commerce Committee

Sep 02, 2026·10:00 AM

Request a transcript

HSE

Full Committee Markup of Twenty-Nine Pieces of Legislation

Energy and Commerce Committee

Jul 20, 2026·5:00 PM ·36m ·7 speakers

HSE

● SPOKEMaintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.

Health Subcommittee

Jul 15, 2026·10:15 AM ·2h 53m ·31 speakers

DeGette, Diana "Thank you so much, Mr. Chairman. I am really excited about this hearing today because I've really worked a lot on biomedical research issues over my career, and I have to I think that I've never seen a more precarious time for the U.S. leadership around the world in biomedical research. The FDA play..."

HSE

● SPOKEThree Pieces of Legislation

Health Subcommittee

Jul 15, 2026·10:00 AM ·39m ·7 speakers

DeGette, Diana "for her five-minute opening statement. Thank you so much, Mr. Chairman. You know, we all want to curb the spread of dangerous illicit drugs, but I'm concerned that these bills fall short of meaningfully improving law enforcement efforts and could further our nation's addiction to criminalization. At..."

HSE

Subcommittee Markup of Six Pieces of Legislation

Energy Subcommittee

Jul 14, 2026·10:15 AM ·1h 15m ·20 speakers

HSE

Nine Pieces of Legislation

Energy and Commerce Committee

Jul 01, 2026·11:00 AM

Request a transcript

HSE

● SPOKEState Medicaid Program Integrity: Examining Fraud Risks and Oversight Deficiencies.

Oversight and Investigations Subcommittee

Jun 25, 2026·10:15 AM ·2h 30m ·24 speakers

DeGette, Diana "And is this a departure from how CMS and California have collaborated in the past? Yes. Thank you. So, CMS, in my view, is going out of its way to blindside blue states while pampering red ones. In fact, CMS has sent letters investigating Medicaid programs in New York, California, Maine, Minnesota, ..."